Automated Cell Counters Market Research Report Information By Product Type (Fluorescence Image-based Cell Counter, Flow Cytometer and Coulter Counter), By Application (Blood Cells, Cell lines, Microbial cells and Others), By End-use (Pharmaceutical & Biotechnology Companies, Hospitals, Diagnostic Laboratories, Research Institutes and Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

Global Automated Cell Counters Market Overview

Automated Cell Counters Market Size was valued at USD 6.1 Billion in 2022. The Automated cell counters market industry is projected to grow from USD 6.4 Billion in 2023 to USD 10.1 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.80% during the forecast period (2023 - 2032).Rising incidence of chronic diseases, increased research activities, point-of-care testing (POCT), growing awareness of preventive healthcare, emerging markets, COVID-19 pandemic, customization and integration, are the key market drivers enhancing the market growth.

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Automated Cell Counters Market Trends

• Rising incidence of chronic diseases is driving the market growth

One of the main factors propelling the market for automated cell counts is the rise in the prevalence of chronic diseases. Cancer, diabetes, cardiovascular disease, autoimmune disorders, and respiratory illnesses are examples of chronic diseases, which are distinguished by their protracted nature and frequently disabling effects. The need for precise, effective, and quick diagnostic technologies, like automated cell counters, has grown dramatically as these illnesses become more widespread worldwide.

To monitor illness progression, therapy effectiveness, and patient health in general for chronic diseases, regular monitoring is frequently necessary. By delivering quick and accurate assessments of blood cell counts, hemoglobin levels, and other hematological parameters, automated cell counters serve a crucial role in this respect. This improves the quality of care for patients with chronic diseases by assisting healthcare practitioners in making knowledgeable decisions and changing treatment programs as necessary.

Improved patient outcomes and less strain on healthcare systems may result from early diagnosis of chronic diseases. Automated cell counters make it possible to detect irregular blood cell counts early on, which can be a sign of more serious health problems. Early disease detection enables prompt treatment, which may stop or delay the progression of the disease and ultimately lower treatment expenses.

The COVID-19 pandemic highlighted the value of diagnostic methods in handling medical emergencies. Despite not being a chronic condition, COVID-19 highlighted the crucial role that automated cell counters play in evaluating patients' immunological responses, tracking the severity of the disease, and supporting therapeutic decision-making. Greater investments and demand for diagnostic technology have resulted from this greater knowledge of these tools. Thus, driving the automated cell counters market revenue.

Automated Cell Counters Market Segment Insights

Automated cell counters Product Type Insights

The automated cell counters market segmentation, based on product type, includes fluorescence image-based cell counter, flow cytometer and coulter counter. The coulter counter segment dominated the market in 2022. Coulter counters are recognized for their exceptional accuracy and precision when it comes to cell counting and sizing. They use the electrical impedance theory to calculate the volume of each cell as it passes through a microscopic hole. This accuracy is crucial since numerous applications, including clinical diagnosis and research, call for precise cell measurements.

Automated cell counters Application Insights

The automated cell counters market segmentation, based on Application, includes blood cells, cell lines, microbial cells and others. The blood cells segment dominated the market in 2022. Anemia, leukemia, lymphoma, and thrombocytopenia are among the hematological conditions that are on the rise worldwide. Blood cell counts are frequently necessary for these disorders to track the development of the disease, assess the effectiveness of treatment, and identify relapses. Automated cell counts are essential for controlling hematological illnesses because they produce accurate data quickly.

Figure 1: Automated Cell Counters Market, by Application, 2022 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Automated cell counters End-use Insights

The automated cell counters market segmentation, based on end-use, includes pharmaceutical & biotechnology companies, hospitals, diagnostic laboratories, research institutes and others. The hospitals category generated the most income in 2022. This is because automated cell counters are in high demand in clinical laboratories for blood analysis. Blood cells must be counted and analyzed by automated cell counters in order to diagnose and treat a range of blood illnesses.

Automated cell counters Regional Insights

By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North America Automated Cell Counters Market dominated this market in 2022 (45.80%). North America is the world leader in biomedical research and development. The region is home to a large number of pharmaceutical enterprises, biotech companies, and academic research centers for drug discovery, clinical trials, and fundamental research. This ongoing research activity fuels the demand for better cell counting machinery. Further, the U.S. Automated cell counters market held the largest market share, and the Canada Automated cell counters market was the fastest growing market in the North America region.

Further, the major countries studied in the market report are The U.S., Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2: AUTOMATED CELL COUNTERS MARKET SHARE BY REGION 2022 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe Automated cell counters market accounts for the second-largest market share. Public health projects focused at disease prevention and early detection are frequently started by European governments and healthcare institutions. These initiatives can include screenings that use computerized cell counters to find those at risk for different illnesses. Further, the German Automated cell counters market held the largest market share, and the UK Automated cell counters market was the fastest growing market in the European region.

The Asia-Pacific Automated Cell Counters Market is expected to grow at the fastest CAGR from 2023 to 2032. Both densely populated urban areas and isolated rural areas make up Asia Pacific's enormous and diversified population. In order to meet a wide range of medical demands, the sheer size of the population generates a significant demand for healthcare services, including diagnostic equipment like automated cell counters. Moreover, China’s automated cell counters market held the largest market share, and the Indian Automated cell counters market was the fastest growing market in the Asia-Pacific region.

Automated cell counters Key Market Players & Competitive Insights

Leading market players are investing heavily in research and development in order to expand their product lines, which will help the automated cell counters market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, automated cell counters industry must offer cost-effective items.

Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the automated cell counters industry to benefit clients and increase the market sector. In recent years, the automated cell counters industry has offered some of the most significant advantages to medicine. Major players in the Automated cell counters market, including Eppendorf, Thermo Fischer Scientific, Countstar Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd, Chemometec A/S, ALIGNEDGENETICS, Beckman Coulter, Inc. (Danaher), Nanoentek, Olympus Corporation, MERCK KGaA, Sysmex Corporation, Agilent Technologies, Inc., Abbott, Nexcelom Bioscience LLC and others, are attempting to increase market demand by investing in research and development operations.

Thermo Fisher Scientific Inc. (Thermo Fisher) delivers medical equipment, analytical instruments, reagents and consumables, software, and services to satisfy the demands of challenging analytical challenges in research, diagnostics, and clinical laboratories. It offers solutions for cellular biology, synthetic biology, and flow cytometry. Mass spectrometry, genetic sequencing, electron microscopy, protein, and molecular biology research equipment are just a few of the many products that the company sells. The company offers services to companies in the environmental, industrial quality, and process control sectors, as well as to academic and research institutes, governmental organizations, pharmaceutical and biotech companies, clinical diagnostic laboratories, and environmental companies. It provides its products and services through its direct sales force, online sales, and third-party distributors across the Americas, Asia-Pacific, and Europe. The headquarters of Thermo Fisher are located in Waltham, Massachusetts, in the US.

Abbott Laboratories (Abbott) discovers, develops, manufactures, and sells a wide range of healthcare products, including branded generic drugs, diagnostic devices, and infant, child, and adult nutritional supplements. Additionally, the company sells a variety of medical devices, including those for heart failure, neuromodulation, electrophysiology, rhythm management, and vascular and structural cardiac devices. Additionally, the company offers nutritional products, minerals, and dietary supplements. It has production facilities all around the world and R&D facilities in the US, China, Colombia, India, Singapore, Spain, and the UK. Africa, the Middle East, Latin America, North America, and the Asia-Pacific area are among the regions where the firm sells its products. Abbott is based in Abbott Park, Illinois, a city in the US.

Key Companies in the automated cell counters market include

• Eppendorf


• Thermo Fischer Scientific


• Countstar, Inc.


• Bio-Rad Laboratories, Inc.


• F. Hoffmann-La Roche Ltd


• Chemometec A/S


• ALIGNEDGENETICS


• Beckman Coulter, Inc. (Danaher)


• Nanoentek


• Olympus Corporation


• MERCK KGaA


• Sysmex Corporation


• Agilent Technologies, Inc.


• Abbott


• Nexcelom Bioscience LLC

Automated cell counters Industry Developments

March 2022:The complete blood count (CBC) and erythrocyte sedimentation rate (ESR) tests are included in Mindray's new BC-700 Series of hematology analyzers.

February 2022:Abacus dx and Luminex have formed a new agreement for the Guava line of flow cytometry tools and supplies. As part of the agreement, Abacus dx will sell Luminex's Guava line of flow cytometry tools and supplies.

June 2022:The FAD approved the Sysmex Corporation's XN-10 hematological analyzer with blood bank mode. A highly developed automated hematology analyzer called the XN-10 is used to count white blood cells.

Automated Cell Counters Market Segmentation

Automated Cell Counters Product Type Outlook

• Fluorescence image-based cell counter


• Flow cytometer


• Coulter counter

• Blood Cells


• Cell lines


• Microbial cells


• Others

Automated Cell Counters End-use Outlook

• Pharmaceutical & biotechnology companies


• Hospitals


• Diagnostic laboratories


• Research institutes


• Others

Automated Cell Counters Regional Outlook

• North America
  
  
  
  • U.S.
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America